Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMineral & Financial Investments Regulatory News (MAFL)

Share Price Information for Mineral & Financial Investments (MAFL)

Share Price is delayed by 15 minutes
Get Live Data
47.50    -0.50 (-1.04%)
Bid:
47.00
Ask:
48.00
Spread: 1.00 (2.128%)
Market Cap: £18.46m
MAFL Live PriceLast checked at - London Stock Exchange

Intraday Mineral & Financial Investments Share Chart

Net Asset Value(s)

7 Jun 2016 07:00

RNS Number : 3401A
Mineral & Financial Invest. Limited
07 June 2016
 

MINERAL & FINANCIAL INVESTMENTS LIMITED

("Mineral & Financial", "MAFL", or the "Company")

 

 NET ASSET VALUE UPDATE

 

MAFL, the AIM quoted resources investment specialist, today announces an NAV and operations update on its activities for the period ended 31st March 2016.

 

 

· Net Asset Value of 6.51p per share (unaudited)

· Ongoing progress on TH Crestgate Iberian asset portfolio

· Continuing to seek further strategic investments

· Investment portfolio holding its value

 

CHAIRMAN'S STATEMENT

We believe that, during the period under review, the markets continued to vacillate between "probably" and "certainly" as to whether US administered rates will be increased in June 2016 at the next US Federal Reserve Board meeting. Administered US interest rates experienced their first rise in eight years when the US Federal Reserve ("Fed") increased the Fed Funds rate from 25 basis points to 50 basis points in December 2015. The Federal Reserve had promised markets to increase its reference rates four times in 2016. This seems less probable, but not impossible.

Metal prices have improved since the beginning of the year, and our metal sectors of choice, zinc and lead, have been amongst the best performing metals, year to date. We believe mining, generally, but precious metals particularly should continue to recover from the lows it reached Q1-2016. The price of gold has been correcting for very nearly 5 years since its peak of ~$1900/oz. of September 2011. In response to this belief we are actively seeking a strategic investment to increase our exposure to the precious metals segment.

Your Company's decision to invest in and provide support to TH Crestgate GmbH, a private Swiss Company, which has invested in 3 projects focused on zinc and lead, appears to have been timely. More work will be required by TH Crestgate on these properties, but there are a number of corporate options in the pipeline, which we understand are being explored.

We are of the mind that rates are likely to rise more slowly than economic performance warrants and financial markets expect. We continue to be cautious towards equity and fixed income markets. Perhaps incongruously, we expect that the metals and mining cycle will progress upwards due to supply shortages, rather than a demand surge. We believe this is because many years of capital shortages for the mining industry have strangled off virtually all exploration programs.

Jacques Vaillancourt

 

CHIEF INVESTMENT OFFICER'S STATEMENT

 

The Net Asset Value per share rose moderately to 6.51p per share during the first quarter as improved sentiment in the commodities market began to take effect.

 

In particular in the investment portfolio, the valuations of our ETFs in zinc, gold and platinum all improved, while our position in Glencore also rose strongly.

 

We also took the opportunity of improved conditions to liquidate some smaller positions in rhodium, uranium and energy exploration.

 

While remaining cautious, we note with interest the improvement in junior mining equity valuations in general, and in particular the recovery of interest and volumes in the Canadian markets. This bodes well for the future, although it would perhaps be premature to say that a full-blown recovery is yet here, especially with the spectre of more than one US rate rise ahead of us.

 

However, it is heartening that many commentators are once again pointing towards zinc as the metal of the moment, given our investment in TH Crestgate and its Iberian zinc portfolio.

 

We continue to assess opportunities at all levels, both in terms of the strategic and the tactical portfolio.

 

 

Alastair Ford

 

 

 

 

For more information:

Katy Mitchell, WH Ireland +44 161 832 2174

Laurence Read, Director +44 20 3289 9923

 

Notes: The net asset value calculation is subject to audit and is made on the basis that the Company has 14,034,562 shares in issue. All listed investments, including investments on ISDX, are valued at the closing bid price as at 31st March 2016. The Company has an investment in one unquoted gold company that is currently valued at the price at which the gold company in question last raised money, although this is subject to review. The Company also has an investment in one unquoted zinc and base metals company, the valuation of which is subject to quarterly review and is currently recognized at cost.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NAVKMGGVFVRGVZM
Date   Source Headline
28th May 20269:22 amRNSHolding(s) in Company
18th Mar 20267:00 amRNSInterim Results
30th Jan 20263:09 pmRNSConversion Of Vested RSUs into Ordinary Shares
28th Jan 20267:00 amRNSHolding(s) in Company
27th Jan 202611:38 amRNSHolding(s) in Company
20th Jan 20261:06 pmRNSResult of AGM
20th Jan 20267:00 amRNS1st Quarter Results
22nd Dec 20257:00 amRNSAudited Results for Year Ended 30 June 2025
22nd Dec 20257:00 amRNSAudited Results for Year Ended 30 June 2025
7th Oct 20252:35 pmRNSDirector/PDMR Shareholding
20th Aug 20258:45 amRNSGrant of RSU's and Exercise of Options
14th Jul 202511:22 amRNSUpdate on Redcorp's Lagoa Salgada EIA Application
12th Jun 20256:18 pmRNSHolding(s) in Company
6th Jun 20259:39 amRNSDirector/PDMR Shareholding
2nd Jun 20257:00 amRNSUnaudited Quarterly Results
22nd May 20255:28 pmRNSDirector/PDMR Shareholding
7th May 20255:21 pmRNSDirector/PDMR Shareholding
7th May 20254:26 pmRNSDirector/PDMR Shareholding
10th Apr 20257:00 amRNSIssue of Equity
20th Mar 20255:13 pmRNSInvestment in Physical Silver
20th Mar 20257:00 amRNSInterim Results for Six Months Ended 31 Dec 24
7th Mar 202511:45 amRNSHolding(s) in Company
4th Feb 20257:00 amRNSInvestment Update: Ascendant
22nd Jan 202512:20 pmRNSDirector/PDMR Shareholding
16th Jan 20251:24 pmRNSReplacement: Unaudited Quarterly Net Asset Value
16th Jan 20257:00 amRNSUnaudited Quarterly Net Asset Value
18th Dec 20242:52 pmRNSResult of AGM
11th Dec 202411:05 amRNSInvestment Update: Ascendant / Redcorp
25th Nov 20242:37 pmRNSHolding(s) in Company
19th Nov 20245:53 pmRNSAudited Results for Year Ended 30 June 2024
1st Nov 202411:03 amRNSInvestment Update: Ascendant / Redcorp
15th Oct 202411:00 amRNSInvestment Update: Redcorp
30th Sep 202411:00 amRNSInvestment Update: Ascendant / Redcorp
19th Sep 20247:00 amRNSInvestment Update: Ascendant / Redcorp
17th Jul 20247:00 amRNSInvestment Update: Redcorp
15th Jul 20247:00 amRNSChange of Nominated Adviser and Broker
12th Jul 20247:00 amRNSDirector Update
13th Jun 20247:00 amRNSUnaudited Quarterly Net Asset Value
29th Apr 20247:00 amRNSDirector Dealing
10th Apr 20244:22 pmRNSHolding(s) in Company
10th Apr 202411:00 amRNSInvestment Update: Ascendant / Redcorp
27th Mar 20247:00 amRNSInterim Results for Six Months Ended 31 Dec 23
29th Feb 20241:01 pmRNSCorrection - Investment Update: Ascendant /Redcorp
29th Feb 20247:00 amRNSInvestment Update: Ascendant / Redcorp
5th Feb 20247:00 amRNSUnaudited Quarterly Net Asset Value
31st Jan 20246:04 pmRNSResult of AGM
8th Jan 20247:00 amRNSDirector Dealing
3rd Jan 202411:00 amRNSInvestment Update: Ascendant / Redcorp
28th Dec 20232:29 pmRNSNotice of AGM and Posting of Annual Report
20th Dec 20235:25 pmRNSAudited Results for Year Ended 30 June 2023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.